881677-23-2

Usage

Molecular structure

1H-Pyrrole-3-carboxaldehyde, 1-[(2,3-dihydro-1,4-benzodioxin-5-yl)sulfonyl]-4-methyl-5-phenylconsists of a pyrrole ring with a carboxaldehyde functional group, a sulfonyl group attached to a 1-4-benzodioxin ring system, a methyl group, and a phenyl group.

Unique structure

The compound's unique structure may lead to a wide range of applications.

Potential applications

Possible uses of 1H-Pyrrole-3-carboxaldehyde, 1-[(2,3-dihydro-1,4-benzodioxin-5-yl)sulfonyl]-4-methyl-5-phenyl- may include pharmaceuticals, agrochemicals, and materials science.

Further research

More research may be necessary to fully understand and exploit the potential uses of 1H-Pyrrole-3-carboxaldehyde, 1-[(2,3-dihydro-1,4-benzodioxin-5-yl)sulfonyl]-4-methyl-5-phenyl-.

Upstream product

• 87474-15-5 2,3-dihydro-1,4-benzodioxine-5-sulfonyl chloride 
• 481053-70-7 4-methyl-5-phenyl-1H-pyrrole-3-carbaldehyde 

Downstream Products

• 881681-08-9 1-[1-(2,3-dihydro-1,4-benzodioxin-5-ylsulfonyl)-4-methyl-5-phenyl-1H-pyrrol-3-yl]-N-methylmethanamine hydrochloride 

Relevant academic research and scientific papers

Proton pump inhibitors

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R 1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R 2 , R 3 and R 4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R 5 and R 6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.

PROTON PUMP INHIBITORS

A proton pump inhibitor containing a compound represented by the formula (I) wherein X and Y are the same or different and each is a bond or a spacer having 1 to 20 carbon atoms in the main chain, R1 is an optionally substituted hydrocarbon group or an optionally substituted heterocyclic group, R2, R3 and R4 are the same or different and each is a hydrogen atom, an optionally substituted hydrocarbon group, an optionally substituted thienyl group, an optionally substituted benzo[b]thienyl group, an optionally substituted furyl group, an optionally substituted pyridyl group, an optionally substituted pyrazolyl group, an optionally substituted pyrimidinyl group, an acyl group, a halogen atom, a cyano group or a nitro group, R5 and R6 are the same or different and each is a hydrogen atom or an optionally substituted hydrocarbon group, which has a superior proton pump action and shows an antiulcer activity and the like after conversion to a proton pump inhibitor in the body, or a salt thereof. or a prodrug thereof is provided.